RNA Analysis / Transcriptomics

RNA Analysis / Transcriptomics

Global RNA Analysis / Transcriptomics Market to Reach US$19.0 Billion by 2030

The global market for RNA Analysis / Transcriptomics estimated at US$7.9 Billion in the year 2023, is expected to reach US$19.0 Billion by 2030, growing at a CAGR of 13.3% over the analysis period 2023-2030. RNA Analysis / Transcriptomics Reagents / Consumables, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$9.7 Billion by the end of the analysis period. Growth in the RNA Analysis / Transcriptomics Instruments segment is estimated at 11.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 14.3% CAGR

The RNA Analysis / Transcriptomics market in the U.S. is estimated at US$2.9 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 14.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.4% and 13.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Global RNA Analysis / Transcriptomics Market - Key Trends & Drivers Summarized

RNA analysis, also known as transcriptomics, is a powerful and essential field in molecular biology that focuses on the study of RNA molecules within a cell or organism. Transcriptomics provides insights into gene expression and regulation by examining the quantity and sequences of RNA transcripts, which are the intermediates between DNA and proteins. This analysis is crucial for understanding cellular functions, identifying biomarkers for diseases, and discovering potential therapeutic targets. Techniques such as RNA sequencing (RNA-Seq), microarrays, and quantitative PCR (qPCR) are commonly used in transcriptomics to measure and compare RNA levels across different conditions or stages of development. These methods allow researchers to construct comprehensive profiles of gene expression, shedding light on the complexities of biological processes and disease mechanisms.

Technological advancements have significantly enhanced the capabilities and applications of RNA analysis. High-throughput sequencing technologies, particularly RNA-Seq, have revolutionized transcriptomics by enabling the precise and comprehensive quantification of RNA transcripts on a genome-wide scale. RNA-Seq provides a more detailed and unbiased view of the transcriptome compared to traditional methods, allowing for the detection of novel transcripts, splice variants, and non-coding RNAs. Additionally, single-cell RNA sequencing (scRNA-Seq) has emerged as a transformative technique that allows for the analysis of gene expression at the single-cell level, revealing cellular heterogeneity and the dynamics of cellular processes with unprecedented resolution. Advances in computational tools and bioinformatics have also played a crucial role in transcriptomics, providing the necessary frameworks for data analysis, integration, and interpretation, thus enabling researchers to derive meaningful biological insights from complex datasets.

The growth in the RNA analysis/transcriptomics market is driven by several factors, including the increasing demand for personalized medicine, advancements in sequencing technologies, and the rising prevalence of chronic diseases and cancer. The shift towards personalized medicine, which aims to tailor treatments based on an individual’s genetic profile, has spurred the need for comprehensive transcriptomic analysis to identify disease-specific biomarkers and therapeutic targets. Continuous improvements in sequencing technologies, resulting in higher accuracy, throughput, and cost-effectiveness, have made transcriptomic studies more accessible and feasible for a broader range of applications. Additionally, the rising incidence of chronic diseases and cancer has increased the focus on understanding the molecular underpinnings of these conditions, driving the adoption of transcriptomics in research and clinical settings. Government initiatives and funding for genomics research, along with collaborations between academic institutions and pharmaceutical companies, are also contributing to the market`s expansion. As a result, the RNA analysis/transcriptomics field is poised for significant growth, with ongoing innovations and applications promising to enhance our understanding of biology and improve healthcare outcomes.

Select Competitors (Total 115 Featured) -

• Agilent Technologies, Inc.
• Beckman Coulter, Inc.
• bioMerieux SA
• Analytik Jena AG
• Ambry Genetics
• Advanced Cell Diagnostics, Inc.
• Bioneer Corporation
• BioChain Institute, Inc.
• Akoya Biosciences, Inc.
• Acobiom
• ADS Biotec, Inc.
• BGI Genomics Co Ltd.
• 10X Genomics
• Biois Co Ltd
• Bertin Technologies, Sas

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.